Silent Drift and Site-level Variance in Clinical AI: Real-world performance and subgroup analysis for post-market monitoring of an FDA-cleared artificial intelligence (AI) triage tool for high-risk use case of pulmonary embolism
Background. FDA-cleared artificial intelligence (AI) triage tool for pulmonary embolism (PE) detection has been widely used; however, its performance has n